porhassan claims he is blinded as to whether the sever/critical patient deaths were leronlimab or placebo. Without a doubt, Patterson is not blinded so apparently Patterson has not communicated the result to Pourhassan. Interesting.

Likely Patterson did not communicate the result to Pourhassan for precisely this reason: That if Pourhassan speaks on the matter of placebo trials prior to an endpoint that is both conclusive and legal, then Pourhassan cannot receive a penalty flag from the FDA.